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Due to the recent emergence of adjunctive techniques such as cardiopulmonary bypass support, left main 
angioplasty may become more routinely applied in the near future. In  order to choose the best possible 
therap-v, a precise risk assessment will be desirable. Twenty-two left main angioplasties were thus reviewed 
and patients were divided in two groups according to a risk score adapted,fiom a previously published 
jeopardy score. Group I includedpatients with a risk score < 6 andgroup IIpatients with a risk score > 6. A 
cutoff criterion of six points was chosen because it represents the maximal amount of myocardium put at 
jeopardyfrom a single coronary stenosis. The success rule ofthe procedure was 77% and was similar in both 
groups. Ofthe I 2  patients in group I ,  two patients underwent in-hospital bypass surgery and one of them 
died. Among the ten patients ofgroup It, one sustained a myocardial infarction, three underwent acute 
surgery, and one palient died postoperatively. After a mean.follow-up of41 months, the total mortality rate 
was 17% in group I and 30% in group II .  The long-term eventfree survival rate was 75% in group I and 
10% in group I1 (P = 0.004). The risk score was found to be a potentially important predictor of sustained 
success (long-term success: 4.4 f 2.9 vs no long-term success: 8.3 f 3.4; P = 0.01), although sophisticated 
statistical analysis was limited by the small number ofpatients. Thus, in patients with a low risk score, 
angioplasty seems to be an appropriate treatment while it appears that surgery should remain the standard 
therupyfbr patients with a calculated high risk score. However, the clinical significance of this new risk score 
remains to be determined with more elaborate statistical analysis applied to a larger number ofpatients. (J  
Interven Cardiol 1990:3:2) 
Introduction 
Over the past two decades, left main (LM) coro- 
nary artery disease has been considered the exclu- 
sive territory of the cardiac surgeon and one of the 
major contraindications to percutaneous translu- 
minal coronary angioplasty (PTCA). ’ Clinical stud- 
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ies have indeed shown an overall though variable 
survival benefit in surgically treated patients in 
comparison to medically treated patients. How- 
ever, as experience in PTCA grew, accompanied by 
technical improvements, increasingly classical 
contraindications to PTCA fell, with a rewarding 
clinical e f f e ~ t . ~ , ~  To date, merely three studies have 
helped to clarify the risks and benefits of left main 
PTCA by stratifying the procedure in “protected” 
and “unprotected” according to the presence of a 
patent graft to the left coronary a r t e r i e ~ ~ , ~  and/or 
presence of collaterals to the left circulation.6 Al- 
beit simple and informative, this classification re- 
mains somewhat imprecise, and because of the re- 
cent emergence of adjunctive techniques, such as 
the percutaneous cardiopulmonary bypass sup- 
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port,’ a better assessment of the amount of myo- 
cardium at risk would be useful to adequately se- 
lect the best therapy for these patients. 
Accordingly, to achieve this goal, we modified 
the concept of the jeopardy score described by Ca- 
liff et a1.,8 which excluded patients with LM dis- 
ease, by incorporating into it the protective effect 
of collaterals and bypass grafts. This article pres- 
ents our acute and long-term results with LM 
PTCA in relation to this “risk score” and discusses 
the available treatment options for LM disease. 
Methods 
Study Patients. Of 2,978 patients who had a 
PTCA procedure performed between September 
1980 and June 1989, 22 patients underwent a 
PTCA of the LM and they constituted the study 
group. Information was obtained by telephone in- 
terviews, hospital databases, mailed question- 
naires, and civil registries. The decisions to per- 
form PTCA were always based on discussions in- 
volving the surgeon and one member of the PTCA 
team. Twelve patients had had previous bypass 
surgery. Of these, I 1  patients, who had patent 
grafts to the left anterior descending artery (LAD) 
and/or the left circumflex artery (LCx), were con- 
sidered to be at low risk of complications and were 
treated with PTCA. The remaining patient (patient 
6) had a proximal total occlusion of the graft and 
was refused for surgery because he had an iatro- 
genic aortic dissection at the time of previous by- 
pass surgery, for which a Dacron patch was in- 
stalled in the ascending aorta. In the ten patients 
without previous bypass, preference was given to 
PTCA because of various medical conditions in six 
patients. These were: chronic renal failure (patients 
1 and 21); age alone (patient 13); age associated 
with severe chronic lung disease (patient 22); se- 
vere peripheral artery disease (patient 3); and se- 
vere obesity (patient 1 8). Patient I4 was in cardio- 
genic shock and had an emergency PTCA. Finally, 
due to the retrospective nature of this study, no 
clear reasons for preferential treatment with PTCA 
could be identified in the remaining patients (pa- 
tients 5, 12, and 16). 
Definition of the Risk Score. Patients were clas- 
sified according to a “risk score” derived from a 
jeopardy score previously described in the litera- 
ture which has been shown to carry important 
prognostic information.8 For this purpose, all an- 
giograms were reviewed by two members of the 
study team and a third one was involved when con- 
sensus could not be reached. The angiograms were 
reviewed without knowledge of patient’s outcome. 
To calculate the score, the coronary circulation 
was divided into six segments (Fig. 1): the distal 
LAD, the major septa1 branch, the major diagonal 
branch, the distal LCx, the major obtuse marginal 
branch and the right coronary artery (RCA). The 
RCA was not included in the calculation except if 
filled by collaterals from LAD and/or LCx because 
only then, did it participate directly in the risk of 
LM dilatation. Each segment distal to a stenosis 
> 50% was attributed 2 points if not filled retro- 
gradely by collaterals from the RCA or a patent 
graft. In the presence of a left dominant system, the 
LCx was considered as three segments instead of 
two. Thus, the maximal score was 12 points, in 
which case there was filling of the RCA from the 
left circulation or a left dominant system, in addi- 
tion to the stenosed LM. The minimal score was 2 
points, in which case all segments, but one, were 
filled via patent grafts or collaterals from RCA. 
After calculation of this risk score, patients were 
arbitrarily divided in two groups. Group I included 
patients with a risk score 2 6 points and group I1 
included those with a score > 6 points. Six points 
was chosen as a convenient cutoff criterion because 
it is the maximal score obtainable from a single 
coronary artery stenosis (e.g., proximal LAD) and, 
therefore, anything greater than this implied an un- 
usually high amount of myocardium at risk. 
Clinical and Angiographic Characteristics of the 
Patients. The clinical and angiographic character- 
istics of the patients are indicated in Table I. Unsta- 
ble angina was defined as crescendo angina, new 
onset angina of a progressive nature, angina at rest 
or early postinfarction angina as proposed by de 
F e ~ t e r . ~  Vessel disease was classified as double 
when the LM stenosis was found with a dominant 
or balanced nonstenotic RCA. It was triple when 
the LM stenosis was accompanied by a > 50% ste- 
nosed dominant or balanced RCA or when there 
was a left dominance.2 Ejection fraction was calcu- 
lated from the contrast ventriculography. 
Procedural Approach. All angioplasties were 
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Figure 1. Calculation of the risk score. The coronary tree is divided into 6 segments to which 2 
points are attributed when there is a > 50% stenosis proximally. The protective effect of grafts 
and/or collaterals (arrows) is assessed. The right coronary artery is calculated only if its flow origi- 
nates from the left circulation. (Diag = main diagonal branch; LCA = left coronary artery; Marg 
= main obtuse marginal branch; PDA = posterior descending artery; Sept = main septa1 branch.) 
performed according to the standard technique in 
use at the time. In three patients (patients 2,9, and 
13), the Sones technique from the right arm was 
used while the Judkins technique was used in the 
others. In patient 16, the "kissing-balloon'' tech- 
nique'' was used and in patient 18, two guidewires 
were used simultaneously (Fig. 2). Prophylactic in- 
sertion of intra-aortic balloon pump (IABP) was 
not used. Nevertheless, an IABP was required for 
two patients. The first one (patient 4) had the lABP 
already in place before the procedure because of 
refractory unstable angina and the second (patient 
14) required it at the time of the PTCA because of 
cardiogenic shock. When multi-lesion dilatation 
was performed in a patient with a significant steno- 
sis of a graft to the left coronary circulation, the 
graft was dilated first. Otherwise, the LM stenosis 
was always the first vessel dilated. Patients received 
250 mg intravenous acetylsalicylic acid and 10,000 
IU of intravenous heparin prior to the procedure 
and they were treated with nifedipine and acetyl- 
salicylic acid afterward. Angiographic success was 
defined as reduction in the stenosis severity to 
< 50% luminal diameter, as assessed by visual in- 
terpretation. Major complications were defined as 
death, acute bypass surgery and nonfatal Q- and 
non-Q-wave myocardial infarction (diagnosed us- 
ing standard serum enzymes and electrocardio- 
graphic criteria). 
Follow-up. Follow-up data were available for all 
patients surviving initial hospitalization. Angio- 
graphic follow-up of the patients was performed as 
clinically indicated. Restenosis was defined as a 
loss of at least 50% of the initial gain achieved." 
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Table I. Clinical and Angiographic Characteristics of Patients with Left Main Stem Coronary Angioplasty 
Risk 
Age Anginal Old Old EF Number RCA score 
Pt (yrs? SD) Sex status AM1 CABG (&SD) ofVD >50% (?SD) Comments 
Group I (Risk Score 2 6) 
2 47 M stable - 
4 62 M unstable Y 
Y 
Y 
0.64 3 
0.38 3 
Y 
Y 
4 
6 2 weeks postinfenor 
2 
2 
4 
AMI/lABP (angina) 
I 63 
8 73 
9 68 
10 63 
I 1  60 
15 62 
17 60 
19 72 
20 63 
22 82 
M 
M 
F 
F 
M 
M 
F 
F 
M 
M 
stable 
stable 
stable 
stable 
unstable 
stable 
stable 
unstable 
stable 
unstable 
Y 
- 
- 
Y 
Y 
Y 
Y 
Y 
Y 
Y 
Y 
Y 
Y 
Y 
- 
0.3 I 3 
0.54 3 
0.65 2 
N/A 3 
0.24 3 
0.57 2 
0.57 2 
0.59 3 
0.52 3 
0.50 2 
Y 
Y 
Y 
Y 
- 
L 
6 
6 
2 
2 
2 
4 RCA gives good 
collaterals to the LAD 
3.5 f 1.7 
- 
Y 
Y 
Y 
- 
Y 
Y 
- 
Total 65 f 8 M = 67% Unst = 33% 58% 92% 0.50 k 0.13 3 = 67% 67% 
Group I1 (Risk Score > 6) 
I 61 M stable - 
3 75 M stable Y 
0.69 2 
0.50 3 
10 
12 
- 
Y LAD fills the occluded 
RCA 
5 49 M stable - 
6 57 M stable - 
0.59 2 
0.65 3 
8 
10 
- 
Y Proximal occlusion of 
the graft 
12 43 M stable - 
13 73 F unstable Y 
14 71 F acute AM1 - 
N/A 2 
0.78 2 
0.63 2 
10 
8 
10 Ant. AMI/Shock/IABP/ 
LM:total occlusion 
16 41 M unstable - 
18 79 F stable - 
21 75 M unstable Y 
0.16 2 
0.59 3 
N/A 3 
10 
12 
12 
Left dominance 
LCx fills the occluded 
RCA 
- 
Y 
Total 62 -+ 13 M = 70% Unst = 40% 30% 
P value 0.6 1 .o I .o 0.2 
10% 
- 
0.65 ? 0.09 3 = 40% 
0.0 1 0.4 
30% 
0.3 
10.2 + 1.4 
- 
AM1 = acute myocardial infarction; Ant. = anterior; CABG = coronary artery bypass grafting; EF = ejection fraction; F = female; M 
= male; N/A = not available; Pt = patient; Unst = unstable; VD = vessel disease; Y = yes; yrs = years. 
Risk score is defined in the text. P < 0.05 is considered statistically significant. 
The need for additional revascularization with re- 
peat PTCA or bypass surgery, anginal status, func- 
tional class (New York Heart Association-NYHA), 
anti-anginal medications and incidence of major 
events (death and myocardial infarction) were as- 
sessed. 
Statistics. Statistical analysis was performed 
with the Fisher’s exact test for discrete variables 
and the Student’s t-test for continuous variables. 
Values are expressed as mean k SD. Differences 
were considered significant at a probability value 
of ~0.05. 
Results 
Table I shows the baseline characteristics. The 
only significant difference found between both 
groups was the lower ejection fraction of group I, 
0.50 k 0.13 compared with 0.45 +- 0.09 for group I1 
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Figure 2A. Left main coronary artery stenosis involving the bifurcation in patient 18. 
(P = 0.01). Table I1 lists the details of the proce- 
dures and the outcomes for each study patient. The 
angiographic overall success mte was 77% and was 
similar in both groups. One patient of each group 
died in-hospital after immediate bypass surgery. 
No other acute complications occurred in patients 
of group 1. In group 11, one patient required urgent 
surgery because of a LCx dissection, and another 
one sustained a nonfatal infarction. After a mean 
follow-up period of 41 months (range: 0.5-81 
months), one more patient of group I and two pa- 
tients of group I1 died. Thus, the total mortality 
rate was 17% and 30% for groups I and 11, respec- 
tively (P = NS). Figure 3 provides a general sum- 
mary of the outcomes of each group. As shown, the 
long-term success of the two groups, defined as im- 
mediate angiographic success without any acute or 
late events, differed significantly from each other. 
Long-term success was achieved in nine patients 
(75%) of group I and in only one patient (10%) of 
group I1 (P = 0.004). Table 111 compares patients 
with and without long-term success. Sustained suc- 
cess was predicted by the risk score, when consid- 
ered as a continuous variable (long-term success: 
4.4 k 2.9 vs no long-term success: 8.3 k 3.4; P 
= 0.0 l), and by history of previous bypass surgery 
(long-term success: 80% vs no long-term success: 
33%: P = 0.04). A follow-up angiogram was ob- 
tained at a mean time of 16.1 ? 26.2 months in 
eight patients (40%) who survived the initial hospi- 
talization. Four patients had a restenosis of the 
LM, of whom three patients necessitated bypass 
surgery. In the remaining patient, the dilated graft 
to the LAD was still patent. Among the four pa- 
tients without LM restenosis, one had a restenosis 
of the dilated LAD for which a re-PTCA was per- 
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Figure 2B. Angioplasty of the same patient using one guiding catheter and two guidewires. The balloon catheter lies in the left anterior 
descending artery. 
formed and one had a restenosis of the previously 
dilated graft and died of an infarction 2 years later. 
Finally, at the time of follow-up, 75% of the surviv- 
ing patients of both groups were NYHA Class I. 
Discussion 
Patients with LM coronary artery disease com- 
prise between 5% and 10% of the patients exam- 
ined for ischemic heart disease. 12-14 Their survival 
with medical therapy has been shown, during the 
1970s, to range between 50%-65% at 3 to 5 
years. 13-17 Since then, therapeutic advances have 
remarkably helped to improve this ominous prog- 
nosis. 
Bypass Surgery. Patients with LM disease are 
now almost always exclusively treated by the sur- 
geon. The reported long-term survival rates have 
been consistently over 80% at 3 to 5 
with an excellent symptomatic improvement. Nev- 
ertheless, according to many early reports of the 
1 97oS,13J4J9-21 there were many subsets of patients 
in which clearly less benefits could be obtained. 
These were patients with low grade stenosis sever- 
ity, normal left ventricular function, left domi- 
nancy, normal and dominant RCA, or patients in a 
low risk category as assessed noninvasively. In ad- 
dition, the mortality rate of surgery has been rela- 
tively high, ranging from 3%- 1 1 % in the same stud- 
ies and it has been even higher (12%-19%) when 
surgery was performed in patients with a left domi- 
nant coronary circulation. 13~14,21,22 
In spite of the technical advances of the last de- 
cade, this high mortality rate has not decreased, in 
part due to treatment of more seriously ill and 
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Figure 2C. End result of the procedure. 
older  patient^.'^,'^ Still, LM stenosis remains now 
one of the most important factors associated with a 
greater relative survival difference of bypass sur- 
gery compared with medical treatment.23.24 
Coronary Angioplasty. Despite the generally 
good surgical results, there will continue to be 
some patients who will be refused surgery for 
various reasons, and to whom PTCA will be of- 
fered. This has been the case of almost all patients 
reported to date, including those of this report. The 
reported immediate success rates have been compa- 
rable to those of the National Heart, Lung, and 
Blood Institute (NHLBI) registry for the total popu- 
lation.’ Nevertheless, since Griintzig’s first re- 
LM stenosis has been accepted as the most 
serious PTCA contraindication because of the high 
risk of the procedure. However, patients with LM 
disease constitute a heterogeneous group and not 
all of them share the same hazards. On the one 
hand, it has been shown, first by Stertzer et and 
Gershony et aL5 and then confirmed by O’Keefe et 
aL4 that patients with so-called “protected” LM 
(with at least one patent graft or collateral to the 
left circulation) had an immediate and long-term 
prognosis comparable to that of the NHLBI regis- 
try for the total population. On the other hand, the 
short- and long-term risk of events in patients with 
“unprotected” LM has been demonstrated to be 
prohibitively high, reaching 9% acute mortality, 
65% late mortality and 23% late bypass ~urgery.~ 
Finally, acute LM PTCA in the context of an in- 
farction, while sometimes life-saving, has carried 
an even more repressive acute mortality rate 
of 50%. 
This Study. The aim of this study was to assess 
the prognostic value of a known coronary artery 
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jeopardy score adapted to LM coronary disease 
(“risk score”). The risk of LM stenosis relates to the 
large proportion of muscle at risk from one single 
occlusive event,26 not only before and during 
PTCA, but also after PTCA if restenosis should oc- 
cur. Stratification of the disease in “protected” and 
“unprotected” brings important prognostic infor- 
mation, as we have seen, but it remains mostly 
qualitative. For example, a patent graft to the left 
circulation could provide blood flow to the distal 
LCx only and still be called protective. In the same 
way, collaterals from the RCA to the left circula- 
tion could protect only a diagonal branch or the 
distal LAD, and so, the amount of myocardium at 
risk from the LM stenosis and the PTCA would 
still be important. To offset this problem we theo- 
rized that, when the estimated amount of muscle 
put in jeopardy is greater than that incurred by a .- 
single vessel PTCA (risk score of 6, for proximal 9 
LAD), an unacceptable high acute and follow-up c 
3 event rate should be expected. Thus, our study pa- 
tients were divided into those with a risk score 5 6 .$ 
and those with a risk score > 6, which was easily 
calculated at the time of cineangiograms review. 2 There were no baseline differences between the % two groups except for ejection fraction that was a 
significantly lower in group I. As expected, this 
group also contained more patients with previous e 
bypass surgery since it contained slightly more pa- $ 
tients with a previous infarction, three-vessel dis- 2 
ease, and diseased RCA. This difference is proba- .s 
bly a reflection of more severe underlying ischemic 5 
cardiac disease. The angiographic success rate was 
77%. The danger of LM PTCA is well illustrated by 8 
the fact that all angiographic failures terminated in 2 
bypass surgery or death. Another point of interest 
is the high restenosis rate of LM PTCA, as reported d 
by Gershony et al.’ or as inferred from the higher 6 
risk of restenosis of proximal Our 50% 2 
restenosis rate supports these observations al- a 
though it is obviously biased by the small size of the 
study, the low rate of angiographic follow-up and 
the fact that repeat angiography was carried out 
only for recurrence of symptoms of ischemia. 
Sophisticated statistical analysis, such as multi- 
ple logistic regression, was judged inappropriate 
because of the small numbers involved and was not 
applied. Nevertheless, our results with LM PTCA 
appeared to be easily dichotomized by the risk 
score. Indeed, at a mean follow-up of 41 months, 
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Risk score 5 6 Risk score * 6 
Patients 
> Failed 1 CABG elective 
1 Death -1 CABG acute 2 
Patients 
10 
1 CABQ elective 
2 CABG acute 7 1  death 
Failed < 
Angio. Success Angio. Success - 1 AM1 procedural 
10 7 
1 PTCA 
2 CABQ elective P 2 Deaths 
Long-term success Long- term success 
9 1 
p = 0.004- 
Figure 3. Early and late outcome of left main angioplasty (AM1 = acute myocardial infarction; Angio = angiographic; CABG = coronary 
artery bypass graft surgery). 
75% of patients with a risk score I 6 had persisting 
long-term success versus 10% of those with a risk 
score > 6 and 83% versus 70% were alive. More- 
over, when analyzed with simple statistical meth- 
ods, the risk score predicted accurately the occur- 
rence of acute or follow-up events (Table 111). 
Thus, we concur with the three other studies of LM 
PTCA that the group of patients evaluated to be at 
and distal portion of the LM and spares the os- 
tium.l2 Consequently, proper fitting of the guiding 
catheter is rarely a problem except for very short 
anatomical variants where a minimal “controlled” 
disengagement of the catheter is ne~essary.~ When 
low risk (risk score I 6 or “protected”) have a good 
prognosis and are reasonable candidates for PTCA. 
We are also in agreement with the judgement that 
the high risk patient (risk score > 6 or “unpro- 
tected”), in view of their poor outcome, should not 
be treated exclusively by PTCA, whenever possi- 
ble. Regrettably, because of our small sample size, 
it was not possible to compare adequately both 
methods of classification. There was a discordance 
only for patient 5, who could have been described 
as protected by his collaterals. Yet, he was actually 
in the high risk group (risk score = 8) owing to the 
filling of only the distal LAD. This patient had a 
bypass operation 2.5 years later. Finally, since our 
risk score was intended to be a precise but simple 
method of LM stenosis assessment, potentially 
useful information such as vessel size and viability 
of myocardium have not been included in this eval- 
uation. 
Adjunctive Treatment and Technical Aspects. 
Atherosclerosis usually involves the midportion 
Table 111. Comparison of Patients With and Without 
Adverse Acute or Late Events 
No 
Acute or adverse 
late events events P value 
N (patients) 
FUP (months) 
Sex (males) 
Age (yrs +. SD) 
Previous AM1 
Previous CABG 
E F  (mean k SD) 
Extent CAD 
(no. 3VD) 
Risk Score 
(mean f SD) 
Mult. PTCA 
Ang. Success 
12 
38.9 k 25.2 
9 (75%) 
61 ? 12 
4 (33%) 
4 (33%) 
0.60 ? 0.15 
5 (42%) 
8.3 k 3.4 
3 (25%) 
8 (67%) 
10 
43.3 k 22.3 
6 (60%) 
66+. 10 
6 (60%) 
8 (80%) 
0.53 k 0.1 1 
1(70%) 
4.4 f 2.9 
4 (40%) 
lO(l00%) 
0.6 
0.6 
0.3 
0.4 
0.04 
0.3 
0.2 
0.01 
0.6 
0.9 
Abbreviations as in previous tables. CAD = coronary artery 
disease; Mult. PTCA = multilesion PTCA. 
Acute events are death, nonfatal infarction, re-PTCA or CABG. 
A P value i 0.05 is considered statistically significant. 
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the disease is also extending into the bifurcation, a 
frequent occurrence, a second guidewire in the 
LCx or LAD may be prudent (Fig. 2). Otherwise, 
the use of two simultaneous balloons may help to 
handle a lesion located at the junction of the LM, 
LAD, and LCx. In the case of patients with an esti- 
mated high risk, consideration may also be given to 
the use of a perfusion balloon catheter, which may 
permit a better tolerance to inflation. IABP has 
also been empirically suggested in such patients as 
a prophylactic measure to lessen the risk of the 
PTCA, should an acute complication occur. In the 
series of O’Keefe et aL4 and Stertzer et a1.,6 only 1 I 
out of 33 and two out of 1 I “unprotected” patients 
had an IABP, respectively. In our study, only one 
patient of group I1 required an IABP because of 
cardiogenic shock. An even more serious consider- 
ation must now be given to the new technique of 
percutaneous cardiopulmonary bypass support.’ 
Shawl et al.29 recently reported 75 high-risk pa- 
tients among whom were I2 LM and 24 inoperable 
patients. During the procedure, there were no 
deaths and there was no need for bypass surgery. 
There were three in-hospital deaths but the other 
complications were not reported. However, the 
same investigators reported earlier their first 43 pa- 
tients and the femoral complications were fre- 
quent: two surgical repairs of femoral arteries, one 
venous thrombosis, two local infections, two pseu- 
doaneurysms; and two femoral nerves weakness.29 
Thus, it is not an innocuous technique, and conse- 
quently, a precise risk assessment will be manda- 
tory in each LM patient in order to maximize the 
benefits. 
Conclusion. The patient presenting with an LM 
stenosis remains a challenge to the clinician. The 
main finding of this study of patients treated with 
LM PTCA is that a simple risk score, based on the 
amount of muscle at jeopardy from this lesion, ap- 
pears to be an important prognostic variable. How- 
ever, this hypothesis needs to be confirmed with 
more sophisticated statistical approaches applied 
to a larger amount of patients. Based on our obser- 
vations, PTCA seems to be an acceptable treat- 
ment option for patients estimated at low risk of 
events, according to this risk score. On the con- 
trary, patients considered to be at high risk have an 
alarmingly low long-term success with PTCA. In 
those patients, surgery should remain the standard 
therapy. 
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